Literature DB >> 7009424

Influence of hospitalization and placebo therapy on blood pressure and sympathetic function in essential hypertension.

V Hossmann, G A FitzGerald, C T Dollery.   

Abstract

The decline in blood pressure (BP) in essential hypertensives following hospitalization may result from: 1) regression toward the mean; 2) reduction of anxiety as patients habituate to a new environment; 3) the placebo effect of medication; and 4) an independent effect of hospitalization itself. A randomized crossover study of 12 essential hypertensives demonstrated a fall in supine blood pressure from 165.0/97.9 +/- 2.3/1.1 mm Hg to 154.3/89.6 +/- 2.7/1.1 mm Hg (p less than 0.005) due to hospitalization. A similar reduction in BP from 164.9/99.5 +/- 8.4/4.1 mm Hg to 151.9/93.4 +/- 4.5/1.9 mm Hg (p less than 0.005) resulted from regression toward the mean and habituation during the study period. Urinary catecholamines fell from 68.7 +/- 5.0 to 55.1 +/- 4.3 micrograms/g creatinine/24 hours (p less than 0.05) due to hospitalization and from 56.1 +/- 5.4 to 49.7 +/- 4.3 micrograms/g creatinine/24 hours (p less than 0.05) with time. Although placebo therapy tended to reduce BP, it failed to do so significantly. When expressed as a percentage of the individual's overall mean, urinary catecholamine excretion fell from 110.5% +/- 3.7% to 89.5% +/- 3.7% (p less than 0.001) during hospitalization and from 105.8% +/- 3.9% to 94.2% +/- 3.9% (p less than 0.05) during the outpatient period. Blood pressure and sympathetic activity rapidly returned to prehospitalization values on discharge. These factors may confound the analysis of drug effects on BP and sympathetic activity in essential hypertensives following admission to hospital.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7009424     DOI: 10.1161/01.hyp.3.1.113

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  11 in total

Review 1.  When is discontinuation of antihypertensive therapy indicated?

Authors:  R E Schmieder; J K Rockstroh
Journal:  Cardiovasc Drugs Ther       Date:  1990-12       Impact factor: 3.727

2.  Effect of environment on blood pressure: home versus hospital.

Authors:  M A Young; D B Rowlands; T J Stallard; R D Watson; W A Littler
Journal:  Br Med J (Clin Res Ed)       Date:  1983-04-16

Review 3.  Catecholamine measurements in clinical medicine.

Authors:  M J Brown
Journal:  Postgrad Med J       Date:  1983-08       Impact factor: 2.401

4.  A clinician looks at the future.

Authors:  C T Dollery
Journal:  Br J Clin Pharmacol       Date:  1982-01       Impact factor: 4.335

5.  Patterns of care for hypertension among hospitalized patients.

Authors:  B S Shankar; R P Russell; J W Southard; E W Schurman
Journal:  Public Health Rep       Date:  1982 Nov-Dec       Impact factor: 2.792

6.  Pafenolol, a new beta 1-selective blocking agent, in mild hypertension. Result of an inpatient study and a subsequent outpatient follow-up.

Authors:  J A Sigurdsson; C Bengtsson; T Bjurö
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

Review 7.  Placebo interventions for all clinical conditions.

Authors:  Asbjørn Hróbjartsson; Peter C Gøtzsche
Journal:  Cochrane Database Syst Rev       Date:  2010-01-20

Review 8.  Evidence for placebo effects on physical but not on biochemical outcome parameters: a review of clinical trials.

Authors:  Karin Meissner; Hans Distel; Ulla Mitzdorf
Journal:  BMC Med       Date:  2007-03-19       Impact factor: 8.775

9.  Twenty-four-hour ambulatory blood pressure monitoring in very elderly patients: Comparison of in-hospital versus home follow-up results.

Authors:  Claudia Cappelleri; Alin Janoschka; Reto Berli; Sibylle Kohler; Ruediger C Braun-Dullaeus; Ludwig T Heuss; Mathias Wolfrum
Journal:  Medicine (Baltimore)       Date:  2017-08       Impact factor: 1.889

10.  Effect of One-Week Salt Restriction on Blood Pressure Variability in Hypertensive Patients with Type 2 Diabetes.

Authors:  Hiroyuki Iuchi; Masaya Sakamoto; Hirofumi Suzuki; Yosuke Kayama; Kennosuke Ohashi; Takeshi Hayashi; Sho Ishizawa; Tamotsu Yokota; Katsuyoshi Tojo; Michihiro Yoshimura; Kazunori Utsunomiya
Journal:  PLoS One       Date:  2016-01-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.